{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T15:22:45Z","timestamp":1781623365704,"version":"3.54.5"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T00:00:00Z","timestamp":1635897600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T00:00:00Z","timestamp":1635897600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Basic Science Research Program through the National Research Foundation of Korea","award":["NRF-2020R1F1A1074898"],"award-info":[{"award-number":["NRF-2020R1F1A1074898"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This retrospective study aimed to evaluate the factors affecting recurrence and visual prognosis in patients with treatment-na\u00efve subfoveal polypoidal choroidal vasculopathy (PCV). Patients who had received three consecutive intravitreal injections of ranibizumab or aflibercept and had reached remission were enrolled. \nThey were divided into a group without recurrence (group 1, 26 eyes) and a group with recurrence (group 2, 121 eyes) and followed up for at least 5\u00a0years. Patients in group 2 received additional treatment for worsening. Logistic regression analysis revealed that a young age of onset (<jats:italic>P<\/jats:italic>\u2009=\u20090.001), high choroidal vascularity index (CVI; <jats:italic>P<\/jats:italic>\u2009=\u20090.019), and presence of choroidal vascular hyperpermeability (CVH; <jats:italic>P<\/jats:italic>\u2009=\u20090.037) were associated with a low risk of recurrence. Multiple regression analysis revealed that recurrence (<jats:italic>P<\/jats:italic>\u2009=\u20090.001), greatest linear dimension (<jats:italic>P<\/jats:italic>\u2009=\u20090.003), and polyp configuration (single or cluster; <jats:italic>P<\/jats:italic>\u2009=\u20090.043) were associated with final visual acuity. Patients without recurrence had a lower age of onset and higher CVI than those with recurrence, and they tended to have CVH. In addition, patients with recurrence, large lesion, and cluster polyps had worse final visual acuity than those without these factors. CVI and CVH may be used to predict recurrence of PCV.<\/jats:p>","DOI":"10.1038\/s41598-021-00904-4","type":"journal-article","created":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T11:04:18Z","timestamp":1635937458000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Recurrence and visual prognostic factors of polypoidal choroidal vasculopathy: 5-year results"],"prefix":"10.1038","volume":"11","author":[{"given":"Joo Young","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo Young","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rae Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirinae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Gun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Hoon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,3]]},"reference":[{"key":"904_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00006982-199010010-00001","volume":"10","author":"LA Yannuzzi","year":"1990","unstructured":"Yannuzzi, L. A., Sorenson, J., Spaide, R. F. & Lipson, B. Idiopathic polypoidal choroidal vasculopathy (IPCV). Retina 10, 1\u20138 (1990).","journal-title":"Retina"},{"key":"904_CR2","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.ophtha.2017.11.019","volume":"125","author":"CMG Cheung","year":"2018","unstructured":"Cheung, C. M. G. et al. Polypoidal choroidal vasculopathy: definition, pathogenesis, diagnosis, and management. Ophthalmology 125, 708\u2013724. https:\/\/doi.org\/10.1016\/j.ophtha.2017.11.019 (2018).","journal-title":"Ophthalmology"},{"key":"904_CR3","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1136\/bjo.2004.049296","volume":"89","author":"M Yuzawa","year":"2005","unstructured":"Yuzawa, M., Mori, R. & Kawamura, A. The origins of polypoidal choroidal vasculopathy. Br. J. Ophthalmol. 89, 602\u2013607. https:\/\/doi.org\/10.1136\/bjo.2004.049296 (2005).","journal-title":"Br. J. Ophthalmol."},{"key":"904_CR4","doi-asserted-by":"publisher","first-page":"16204","DOI":"10.1038\/srep16204","volume":"5","author":"M Miyake","year":"2015","unstructured":"Miyake, M. et al. Pachychoroid neovasculopathy and age-related macular degeneration. Sci. Rep. 5, 16204. https:\/\/doi.org\/10.1038\/srep16204 (2015).","journal-title":"Sci. Rep."},{"key":"904_CR5","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1016\/j.ophtha.2015.05.012","volume":"122","author":"L Ma","year":"2015","unstructured":"Ma, L. et al. Association of genetic variants with polypoidal choroidal vasculopathy: a systematic review and updated meta-analysis. Ophthalmology 122, 1854\u20131865. https:\/\/doi.org\/10.1016\/j.ophtha.2015.05.012 (2015).","journal-title":"Ophthalmology"},{"key":"904_CR6","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.preteyeres.2016.04.002","volume":"53","author":"CW Wong","year":"2016","unstructured":"Wong, C. W. et al. Age-related macular degeneration and polypoidal choroidal vasculopathy in Asians. Prog. Retin. Eye Res. 53, 107\u2013139. https:\/\/doi.org\/10.1016\/j.preteyeres.2016.04.002 (2016).","journal-title":"Prog. Retin. Eye Res."},{"key":"904_CR7","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.1167\/iovs.14-16236","volume":"56","author":"G Coscas","year":"2015","unstructured":"Coscas, G. et al. Toward a specific classification of polypoidal choroidal vasculopathy: idiopathic disease or subtype of age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 56, 3187\u20133195. https:\/\/doi.org\/10.1167\/iovs.14-16236 (2015).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"904_CR8","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.survophthal.2010.03.004","volume":"55","author":"Y Imamura","year":"2010","unstructured":"Imamura, Y., Engelbert, M., Iida, T., Freund, K. B. & Yannuzzi, L. A. Polypoidal choroidal vasculopathy: a review. Surv. Ophthalmol. 55, 501\u2013515. https:\/\/doi.org\/10.1016\/j.survophthal.2010.03.004 (2010).","journal-title":"Surv. Ophthalmol."},{"key":"904_CR9","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1001\/jamaophthalmol.2017.4030","volume":"135","author":"A Koh","year":"2017","unstructured":"Koh, A. et al. Efficacy and safety of ranibizumab with or without verteporfin photodynamic therapy for polypoidal choroidal vasculopathy a randomized clinical trial. JAMA Ophthalmol. 135, 1206\u20131213. https:\/\/doi.org\/10.1001\/jamaophthalmol.2017.4030 (2017).","journal-title":"JAMA Ophthalmol."},{"key":"904_CR10","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1001\/jamaophthalmol.2018.1804","volume":"136","author":"WK Lee","year":"2018","unstructured":"Lee, W. K. et al. Efficacy and safety of intravitreal aflibercept for polypoidal choroidal vasculopathy in the PLANET study: a randomized clinical trial. JAMA Ophthalmol. 136, 786\u2013793. https:\/\/doi.org\/10.1001\/jamaophthalmol.2018.1804 (2018).","journal-title":"JAMA Ophthalmol."},{"key":"904_CR11","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1097\/IAE.0b013e31816577cb","volume":"28","author":"E Akaza","year":"2008","unstructured":"Akaza, E., Mori, R. & Yuzawa, M. Long-term results of photodynamic therapy of polypoidal choroidal vasculopathy. Retina 28, 717\u2013722. https:\/\/doi.org\/10.1097\/IAE.0b013e31816577cb (2008).","journal-title":"Retina"},{"key":"904_CR12","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s10384-010-0886-x","volume":"55","author":"E Akaza","year":"2011","unstructured":"Akaza, E., Yuzawa, M. & Mori, R. Three-year follow-up results of photodynamic therapy for polypoidal choroidal vasculopathy. Jpn. J. Ophthalmol. 55, 39\u201344. https:\/\/doi.org\/10.1007\/s10384-010-0886-x (2011).","journal-title":"Jpn. J. Ophthalmol."},{"key":"904_CR13","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.ajo.2012.09.020","volume":"155","author":"HM Kang","year":"2013","unstructured":"Kang, H. M., Kim, Y. M. & Koh, H. J. Five-year follow-up results of photodynamic therapy for polypoidal choroidal vasculopathy. Am. J. Ophthalmol. 155, 438-447 e431. https:\/\/doi.org\/10.1016\/j.ajo.2012.09.020 (2013).","journal-title":"Am. J. Ophthalmol."},{"key":"904_CR14","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1007\/s00417-020-04620-z","volume":"258","author":"K Lee","year":"2020","unstructured":"Lee, K., Park, J. H., Park, Y. G. & Park, Y. H. Analysis of choroidal thickness and vascularity in patients with unilateral polypoidal choroidal vasculopathy. Graefes Arch. Clin. Exp. Ophthalmol. 258, 1157\u20131164. https:\/\/doi.org\/10.1007\/s00417-020-04620-z (2020).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"904_CR15","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1097\/IAE.0000000000001481","volume":"37","author":"P Gupta","year":"2017","unstructured":"Gupta, P. et al. Detailed characterization of choroidal morphologic and vascular features in age-related macular degeneration and polypoidal choroidal vasculopathy. Retina 37, 2269\u20132280. https:\/\/doi.org\/10.1097\/IAE.0000000000001481 (2017).","journal-title":"Retina"},{"key":"904_CR16","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1097\/IAE.0b013e318285cbb3","volume":"33","author":"LH Yang","year":"2013","unstructured":"Yang, L. H., Jonas, J. B. & Wei, W. B. Optical coherence tomographic enhanced depth imaging of polypoidal choroidal vasculopathy. Retina 33, 1584\u20131589. https:\/\/doi.org\/10.1097\/IAE.0b013e318285cbb3 (2013).","journal-title":"Retina"},{"key":"904_CR17","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s00417-017-3591-3","volume":"255","author":"M Bakthavatsalam","year":"2017","unstructured":"Bakthavatsalam, M. et al. Choroidal structures in polypoidal choroidal vasculopathy, neovascular age-related maculopathy, and healthy eyes determined by binarization of swept source optical coherence tomographic images. Graefes Arch. Clin. Exp. Ophthalmol. 255, 935\u2013943. https:\/\/doi.org\/10.1007\/s00417-017-3591-3 (2017).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"904_CR18","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1097\/IAE.0000000000001312","volume":"37","author":"X Wei","year":"2017","unstructured":"Wei, X. et al. CHOROIDAL VASCULARITY INDEX: a novel optical coherence tomography based parameter in patients with exudative age-related macular degeneration. Retina 37, 1120\u20131125. https:\/\/doi.org\/10.1097\/IAE.0000000000001312 (2017).","journal-title":"Retina"},{"key":"904_CR19","first-page":"1023","volume":"6","author":"R Agrawal","year":"2010","unstructured":"Agrawal, R. et al. Choroidal vascularity index as a measure of vascular status of the choroid: measurements in healthy eyes from a population-based study. Sci. Rep. Uk 6, 1023 (2010).","journal-title":"Sci. Rep. Uk"},{"key":"904_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0101057","volume":"9","author":"CM Cheung","year":"2014","unstructured":"Cheung, C. M. et al. A prospective study of treatment patterns and 1-year outcome of Asian age-related macular degeneration and polypoidal choroidal vasculopathy. PLoS ONE 9, e101057. https:\/\/doi.org\/10.1371\/journal.pone.0101057 (2014).","journal-title":"PLoS ONE"},{"key":"904_CR21","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ajo.2015.12.024","volume":"164","author":"DS Ting","year":"2016","unstructured":"Ting, D. S. et al. Choroidal thickness changes in age-related macular degeneration and polypoidal choroidal vasculopathy: a 12-month prospective study. Am. J. Ophthalmol. 164, 128-136 e121. https:\/\/doi.org\/10.1016\/j.ajo.2015.12.024 (2016).","journal-title":"Am. J. Ophthalmol."},{"key":"904_CR22","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1111\/ceo.13467","volume":"47","author":"B Liu","year":"2019","unstructured":"Liu, B., Zhang, X., Mi, L., Peng, Y. & Wen, F. Choroidal structure in subtypes of polypoidal choroidal vasculopathy determined by binarization of optical coherence tomographic images. Clin. Exp. Ophthalmol. 47, 631\u2013637. https:\/\/doi.org\/10.1111\/ceo.13467 (2019).","journal-title":"Clin. Exp. Ophthalmol."},{"key":"904_CR23","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/s0002-9394(02)01404-6","volume":"133","author":"M Uyama","year":"2002","unstructured":"Uyama, M. et al. Polypoidal choroidal vasculopathy: natural history. Am. J. Ophthalmol. 133, 639\u2013648. https:\/\/doi.org\/10.1016\/s0002-9394(02)01404-6 (2002).","journal-title":"Am. J. Ophthalmol."},{"key":"904_CR24","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.ajo.2012.03.051","volume":"154","author":"YA Lee","year":"2012","unstructured":"Lee, Y. A. et al. Photodynamic therapy with or without intravitreal bevacizumab for polypoidal choroidal vasculopathy: two years of follow-up. Am. J. Ophthalmol. 154, 872\u2013880. https:\/\/doi.org\/10.1016\/j.ajo.2012.03.051 (2012).","journal-title":"Am. J. Ophthalmol."},{"key":"904_CR25","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.ajo.2011.01.002","volume":"151","author":"A Tsujikawa","year":"2011","unstructured":"Tsujikawa, A. et al. Association of lesion size and visual prognosis to polypoidal choroidal vasculopathy. Am. J. Ophthalmol. 151, 961-972 e961. https:\/\/doi.org\/10.1016\/j.ajo.2011.01.002 (2011).","journal-title":"Am. J. Ophthalmol."},{"key":"904_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajo.2016.02.019","volume":"165","author":"HJ Cho","year":"2016","unstructured":"Cho, H. J. et al. Intravitreal aflibercept and ranibizumab injections for polypoidal choroidal vasculopathy. Am. J. Ophthalmol. 165, 1\u20136. https:\/\/doi.org\/10.1016\/j.ajo.2016.02.019 (2016).","journal-title":"Am. J. Ophthalmol."},{"key":"904_CR27","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1097\/Iae.0000000000001758","volume":"38","author":"Y Yanagi","year":"2018","unstructured":"Yanagi, Y. et al. Choroidal vascular hyperpermeability as a predictor of treatment response for polypoidal choroidal vasculopathy. Retina-J. Ret. Vit. Dis. 38, 1509\u20131517. https:\/\/doi.org\/10.1097\/Iae.0000000000001758 (2018).","journal-title":"Retina-J. Ret. Vit. Dis."},{"key":"904_CR28","doi-asserted-by":"publisher","first-page":"3893","DOI":"10.1167\/iovs.14-14447","volume":"55","author":"S Sonoda","year":"2014","unstructured":"Sonoda, S. et al. Choroidal structure in normal eyes and after photodynamic therapy determined by binarization of optical coherence tomographic images. Invest. Ophthalmol. Vis. Sci. 55, 3893\u20133899. https:\/\/doi.org\/10.1167\/iovs.14-14447 (2014).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"904_CR29","doi-asserted-by":"publisher","first-page":"7868","DOI":"10.1038\/s41598-017-08276-4","volume":"7","author":"DSW Ting","year":"2017","unstructured":"Ting, D. S. W. et al. Choroidal remodeling in age-related macular degeneration and polypoidal choroidal vasculopathy: a 12-month prospective study. Sci. Rep. 7, 7868. https:\/\/doi.org\/10.1038\/s41598-017-08276-4 (2017).","journal-title":"Sci. Rep."},{"key":"904_CR30","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3928\/1081-597X-19970701-16","volume":"13","author":"JT Holladay","year":"1997","unstructured":"Holladay, J. T. Proper method for calculating average visual acuity. J. Refract. Surg. 13, 388\u2013391 (1997).","journal-title":"J. Refract. Surg."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-00904-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-00904-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-00904-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T16:49:23Z","timestamp":1670086163000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-00904-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,3]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["904"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-00904-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,3]]},"assertion":[{"value":"15 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21572"}}